Showing 1-9 of 9 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Upscaling SC-islet manufacturing | Leiden University Medical Center | Françoise Carlotti | Cures | 01-March-2026 to 29-February-2028 | $599.998,36 |
| 6-bromotryptophan (6BT) as new oral treatment for patients with Type 1 diabetes mellitus | Amsterdam UMC Research BV | Max Nieuwdorp | Cures | 01-November-2025 to 31-October-2029 | $1.501.955,00 |
| Multiscale visible-LIGHT bioprinting of vascularized, durable therapeutic stem cell islets with enhanced enGRAFTment capacity (LIGHTGRAFT) | Utrecht University | Riccardo Levato | Cures | 01-September-2025 to 31-August-2028 | $2.240.262,80 |
| Metabolic aspect of autoimmunity | Leiden University Medical Center | Arnaud Zaldumbide | Cures | 01-June-2024 to 31-May-2026 | $499.688,00 |
| Individualised Care From Early Risk of Cardiovascular Disease to Established Heart Failure (iCare4CVD) | Maastricht University | Hans Peter Brunner-La Rocca | Improving Lives | 01-October-2023 to 30-September-2028 | $2.416.634,00 |
| Identifying barriers and facilitators of self-care and its link with mental and cognitive health in older persons with T1D | Amsterdam UMC Research BV | Frank Snoek | Improving Lives | 01-August-2023 to 31-July-2026 | $979.028,07 |
| MELISSA: mobile artificial intelligence solution for diabetes adaptive care | Maastricht University | Bastiaan De Galan | Improving Lives | 21-October-2022 to 20-October-2025 | $200.000,00 |
| The Effectiveness of MyDiaMate, a Self-guided Web-based App for Mental Health in Type 1 Diabetes: a Multinational Randomized Controlled Trial | Amsterdam UMC Research BV | Frank Snoek | Improving Lives | 01-November-2022 to 31-October-2026 | $999.544,40 |
| Ambrisentan and Sotagliflozin for Prevention of renal Injury; a Randomized Evaluation (ASPIRE)ASPIRE | University Medical Center Groningen | Hiddo Lambers Heerspink | Improving Lives | 01-October-2023 to 30-September-2026 | $1.183.690,64 |